InvestorsHub Logo

sukus

03/07/24 3:25 PM

#677131 RE: dennisdave #677118

With the help of Advents, UCLA and several well respected Doctors, this tiny biotech could do it.

They didn’t talk much but the milestones achieved so far speak volumes.

You didn’t notice it?

Did you notice in the 10K that NWBO would improve FlaskWorks?

Did you notice in the 10K that NWBO would enhance Dendritic Cells to be the next generation?

Did you notice about soon to be combination trials in the 10k?


When you read above updates in the 10 K, did it come up in your mind about a company that sits idle ready to be swallowed by a competitor?

skitahoe

03/07/24 4:29 PM

#677156 RE: dennisdave #677118

They are ready, the Sawston facility has been approved in the UK where they're applying for approval. I'm not saying the facility can meet the full demand, but I believe capacity is being increased and the EDEN approval may be possible by that time. The point is, they can sell the DCVax-L from day one, the demand may be many times what they can initially be delivered, but as long as the cancer is being properly preserved they'll have an opportunity to get caught up.

I believe that once approval occurs the company could make further announcements on how they intend to meet demand.

Gary
Bullish
Bullish